中药逆转卵巢癌多药耐药的研究现状  

Current status of traditional Chinese medicine on reversing multidrug resistance in ovarian cancer

作　　者：许岚 袁泽婷 殷佩浩 樊伯珍[2] XU Lan;YUAN Ze-ting;YIN Pei-hao;FAN Bo-zhen(Putuo Clinical Medical School,Shanghai University of Traditional Chinese Medicine,Shanghai 200062,China;Department of Obstetrics and Gynecology,Putuo Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200062,China;Interventional Cancer Institute of Chinese Integrative Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200062,China)

机构地区：[1]上海中医药大学普陀临床医学院,上海200062 [2]上海中医药大学附属普陀医院妇产科,上海200062 [3]上海中医药研究院中西医结合肿瘤介入研究所,上海200062

出　　处：《中国临床药理学杂志》2021年第11期1463-1466,共4页The Chinese Journal of Clinical Pharmacology

摘　　要：卵巢癌多药耐药的发生机制极其复杂,且不明确。随着研究深入,中药逆转卵巢癌多药耐药的可行性越来越大。本文总结了近年来对卵巢癌多药耐药发生机制的研究及中药逆转治疗的进展,希望通过本次归纳可以为中药发挥抗肿瘤治疗提供新的思路。The pathogenesis of multidrug resistance in ovarian cancer is extremely complex and unclear. With the deepening of research, the feasibility of traditional Chinese medicine to reverse multi-drug resistance of ovarian cancer is increasing. This paper summarizes the recent researches on the mechanism of multidrug resistance in ovarian cancer and the progress of traditional Chinese medicine reverse treatment. It is hoped that this conclusion can provide new ideas for anti-tumor treatment of traditional Chinese medicine.

关 键 词：中药 卵巢癌 多药耐药 

分 类 号：R28[医药卫生—中药学]